ID: ALA4648940
Max Phase: Preclinical
Molecular Formula: C16H15N3O
Molecular Weight: 265.32
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Oc1cc(CCc2ccccc2)nn1-c1ccccn1
Standard InChI: InChI=1S/C16H15N3O/c20-16-12-14(10-9-13-6-2-1-3-7-13)18-19(16)15-8-4-5-11-17-15/h1-8,11-12,20H,9-10H2
Standard InChI Key: PYXQCMGZXSLTHA-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 265.32 | Molecular Weight (Monoisotopic): 265.1215 | AlogP: 2.76 | #Rotatable Bonds: 4 |
| Polar Surface Area: 50.94 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 4.49 | CX Basic pKa: 2.22 | CX LogP: 3.63 | CX LogD: 2.05 |
| Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.79 | Np Likeness Score: -1.34 |
| 1. Tsuganezawa K, Sekimata K, Nakagawa Y, Utata R, Nakamura K, Ogawa N, Koyama H, Shirouzu M, Fukami T, Kita K, Tanaka A.. (2020) Identification of small molecule inhibitors of human COQ7., 28 (1): [PMID:31753803] [10.1016/j.bmc.2019.115182] |
Source(1):
